Elan (ELN +1.1%) bounces back into the green after an early morning dip on the back of a UBS downgrade to Neutral. The firm cites a lack of visibility following its announcement that it's divesting a 50% stake in Tysabri to Biogen Idec (BIIB). The price target is also lowered to $10.06.
Are you Bullish or Bearish on ?
Results for ()
Thanks for sharing your thoughts.
From other sites
at Fox Business (Feb 13, 2014)
at CNBC.com (Dec 16, 2013)
at Fox Business (Sep 19, 2013)
at CNBC.com (Sep 5, 2013)
at MarketWatch.com (Aug 14, 2013)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs